“
TL;DR
Limitations include the need for further in vivo blocking assays to confirm the pathway's role and the lack of investigation into the PERK signaling pathway.
Journal of Inflammation (London, England) · 10 authors, 1 centre
This summary was generated by AI from a single paper. It has not been reviewed by a clinician and is not clinical advice. Verify against the source before acting on it.
Limitations include the need for further in vivo blocking assays to confirm the pathway's role and the lack of investigation into the PERK signaling pathway.
Limitations include the need for further in vivo blocking assays to confirm the pathway's role and the lack of investigation into the PERK signaling pathway.